Form 4 holding
Chief Commercial Officer
AVADEL PHARMACEUTICALS PLC
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 147,000
- Estimated value
- Report date
- 20 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- ADSs
- Underlying amount